Nemes Rush Group LLC Emergent Bio Solutions Inc. Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
A detailed history of Nemes Rush Group LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 42 shares of EBS stock, worth $330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 42
-0.0%
Holding current value
$330
Previous $107,000
167.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EBS
# of Institutions
154Shares Held
30.2MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$28.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.17MShares$24.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$9.78 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$7.45 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $392M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...